ducovest

MDYG:ARCA-SPDR S&P 400 Mid Cap Growth ETF (based on S&P MidCap 400 Growth Index--symbol: MUV)

ETF | Mid-Cap Growth | NYSE Arca

Last Closing

USD 52.36

Change

-0.07 (-0.13)%

Market Cap

USD 0.42B

Volume

0.06M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P MidCap 400 Growth Index that tracks the performance of medium capitalization exchange traded U.S. equity securities exhibiting "growth" characteristics. The fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index measures the performance of the mid-capitalization growth segment of the U.S. equity market. The fund is non-diversified.

Company Website : www.spdrs.com

Currency: USD

Country : USA

Inception Date: 08/11/2005

Primary Benchmark: S&P MidCap 400 Growth TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.15%

Management Expense Ratio: 0.15 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
TARS Tarsus Pharmaceuticals Inc 1.37 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-03-19 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Mer Price(Change) Market Cap
VOT Vanguard Mid-Cap Growth Index .. 0.07 %

-1.08 (-0.49%)

 USD 24.16B
IWP iShares Russell Mid-Cap Growth.. 0.24 %

-0.52 (-0.49%)

 USD 14.98B
IJK iShares S&P Mid-Cap 400 Growth.. 0.24 %

-0.31 (-0.36%)

 USD 9.44B
XMMO Invesco S&P MidCap Momentum ET.. 0.39 %

-0.69 (-0.64%)

 USD 1.60B
IVOG Vanguard S&P Mid-Cap 400 Growt.. 0.20 %

-0.45 (-0.42%)

 USD 0.78B
RFG Invesco S&P MidCap 400® Pure .. 0.35 %

-0.33 (-0.70%)

 USD 0.31B
IPO Renaissance IPO ETF 0.60 %

-0.04 (-0.09%)

 USD 0.18B
ETHO Etho Climate Leadership U.S. E.. 0.45 %

-0.11 (-0.20%)

 USD 0.18B
CWS AdvisorShares Focused Equity E.. 0.68 %

-0.16 (-0.27%)

 USD 0.14B
BFOR Barron's 400 ETF 0.65 %

-0.06 (-0.10%)

 USD 0.14B

ETFs Containing MDYG

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.20% 28% F 65% D
Dividend Return 0.30% 60% D- 12% F
Total Return 14.50% 33% F 64% D
Trailing 12 Months  
Capital Gain -2.21% 35% F 47% F
Dividend Return 0.88% 73% C 13% F
Total Return -1.33% 35% F 41% F
Trailing 5 Years  
Capital Gain 36.89% 54% F 76% C+
Dividend Return 7.47% 85% B 25% F
Total Return 44.36% 54% F 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 8.49% 47% F 77% C+
Dividend Return 9.88% 53% F 74% C
Total Return 1.38% 88% B+ 28% F
Risk Return Profile  
Volatility (Standard Deviation) 10.18% 65% D 66% D+
Risk Adjusted Return 97.04% 76% C+ 85% B
Market Capitalization 0.42B 83% B 65% D

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike